A citation-based method for searching scientific literature

Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade, André Robidoux, Richard G Margolese, Joan James, Carolyn D Runowicz, Patricia A Ganz, Steven E Reis, Worta McCaskill-Stevens, Leslie G Ford, V Craig Jordan, Norman Wolmark. Cancer Prev Res (Phila) 2010
Times Cited: 394



Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz, Bernardo Bonanni, Tiina Palva, Anthony Howell. Lancet 2014
Times Cited: 350




List of shared articles



Times cited

Breast Cancer Risk Assessment and Management of the High-Risk Patient.
Victoria L Green. Obstet Gynecol Clin North Am 2022
0

Extraction of Electronic Health Record Data using Fast Healthcare Interoperability Resources for Automated Breast Cancer Risk Assessment.
Julia E McGuinness, Tianmai M Zhang, Kevin Cooper, Arusha Kelkar, Jill Dimond, Virginia Lorenzi, Katherine D Crew, Rita Kukafka. AMIA Annu Symp Proc 2022
0

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.
Brittany Bychkovsky, Alison Laws, Fisher Katlin, Marybeth Hans, Mary Knust Graichen, Lydia E Pace, Rochelle Scheib, Judy E Garber, Tari A King. Breast Cancer Res Treat 2022
0

Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians.
Courtney Macdonald, Christobel M Saunders, Louise A Keogh, Morgan Hunter, Danielle Mazza, Sue-Anne McLachlan, Sandra C Jones, Stephanie Nesci, Michael L Friedlander, John L Hopper,[...]. Cancer Prev Res (Phila) 2021
2


Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
131

Endocrine prevention of breast cancer.
Nusrat Jahan, Catherine Jones, Rakhshanda Layeequr Rahman. Mol Cell Endocrinol 2021
0

Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.
Amy Farkas, Rachel Vanderberg, Sarah Merriam, Deborah DiNardo. J Womens Health (Larchmt) 2020
5

Assessment and management of B3 breast lesions with atypia: a focused review.
M U Ugurlu, T Yoldemir, B M Gulluoglu. Climacteric 2020
1


Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-Situ.
Bradley C Bandera, Amy Voci, Daniel W Nelson, Stacey Stern, Dany Barrak, Trevan D Fischer, Maggie L DiNome, Melanie Goldfarb. Clin Breast Cancer 2020
0

Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study.
Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D Liu, Angelica M Gutierrez-Barrera, Therese B Bevers, Vicente Valero, Nour Sneige, Banu K Arun. Cancer Prev Res (Phila) 2020
2

Estrogen Receptor Positive and Progesterone Receptor Negative Breast Cancer: the Role of Hormone Therapy.
Robert Dembinski, Vishnu Prasath, Carisa Bohnak, Charalampos Siotos, Mohamad E Sebai, Kevin Psoter, Faiz Gani, Joe Canner, Melissa S Camp, Armina Azizi,[...]. Horm Cancer 2020
5

Key steps for effective breast cancer prevention.
Kara L Britt, Jack Cuzick, Kelly-Anne Phillips. Nat Rev Cancer 2020
109

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
63


An Update on Screening and Prevention for Breast and Gynecological Cancers in Average and High Risk Individuals.
Anahid M Pahlawanian, Vanessa A Norris, Amelia M Jernigan, Brooke Morrell, Mignonne Morrell, Navya Nair, Amber M Karamanis, Erin M Dauchy, Michelle M Loch, Agustin A Garcia. Am J Med Sci 2020
0


Chemoprevention acceptance and adherence in women with high-risk breast lesions.
Constance A Roche, Rong Tang, Suzanne B Coopey, Kevin S Hughes. Breast J 2019
7

Global Disparities in Breast Cancer Genetics Testing, Counselling and Management.
C H Yip, D G Evans, G Agarwal, I Buccimazza, A Kwong, R Morant, I Prakash, C Y Song, N A Taib, C Tausch,[...]. World J Surg 2019
9

Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for Cancer.
Goli Samimi, Brandy M Heckman-Stoddard, Shelley S Kay, Bonny Bloodgood, Kisha I Coa, Jennifer L Robinson, Bethany Tennant, Leslie G Ford, Eva Szabo, Lori Minasian. Cancer Prev Res (Phila) 2019
6

Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent.
Burcu Z Ozdemir, Joel B Goodin, Donald L Bodenner. Breast Cancer (Dove Med Press) 2019
1

Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report.
Xinyi Jiang, Julia E McGuinness, Margaret Sin, Thomas Silverman, Rita Kukafka, Katherine D Crew. JCO Clin Cancer Inform 2019
7

Risk-reducing medications for primary breast cancer: a network meta-analysis.
Simone Mocellin, Annabel Goodwin, Sandro Pasquali. Cochrane Database Syst Rev 2019
10

Gene expression signature of atypical breast hyperplasia and regulation by SFRP1.
Kelly J Gregory, Amy L Roberts, Erin M Conlon, Jacob A Mayfield, Mary J Hagen, Giovanna M Crisi, Brooke A Bentley, Jeffrey J Kane, Grace Makari-Judson, Holly S Mason,[...]. Breast Cancer Res 2019
7

Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention.
Pirashaanthy Tharmapalan, Mathepan Mahendralingam, Hal K Berman, Rama Khokha. EMBO J 2019
31

Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.
Annet Bens, Rikke Langballe, Jonine L Bernstein, Deirdre Cronin-Fenton, Søren Friis, Lene Mellemkjaer. Acta Oncol 2019
1


Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
152

Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer.
Chelsea Anderson, Hazel B Nichols, Melissa House, Dale P Sandler. Cancer Prev Res (Phila) 2019
4


Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
59

Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update.
Kala Visvanathan, Carol J Fabian, Elissa Bantug, Abenaa M Brewster, Nancy E Davidson, Andrea DeCensi, Justin D Floyd, Judy E Garber, Erin W Hofstatter, Seema A Khan,[...]. J Clin Oncol 2019
62

Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians.
Somedeb Ball, Meily Arevalo, Edna Juarez, J Drew Payne, Catherine Jones. Prev Med 2019
7

Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention.
Katherine D Crew, Thomas B Silverman, Alejandro Vanegas, Meghna S Trivedi, Jill Dimond, Jennie Mata, Margaret Sin, Tarsha Jones, Mary Beth Terry, Wei-Yann Tsai,[...]. Contemp Clin Trials Commun 2019
3


How Do We Approach Benign Proliferative Lesions?
Faina Nakhlis. Curr Oncol Rep 2018
5

Personalized prevention in high risk individuals: Managing hormones and beyond.
D Gareth Evans, Sacha J Howell, Anthony Howell. Breast 2018
14



A Way Forward for Cancer Chemoprevention: Think Local.
Luai Al Rabadi, Raymond Bergan. Cancer Prev Res (Phila) 2017
12

Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.
Michael S Shawky, Hilary Martin, Honor J Hugo, Thomas Lloyd, Kara L Britt, Andrew Redfern, Erik W Thompson. Oncotarget 2017
25

Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.
Savitri Krishnamurthy, Therese Bevers, Henry M Kuerer, Benjamin Smith, Wei Tse Yang. AJR Am J Roentgenol 2017
6

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.
Kelly K Hunt, David M Euhus, Judy C Boughey, Anees B Chagpar, Sheldon M Feldman, Nora M Hansen, Swati A Kulkarni, David R McCready, Eleftherios P Mamounas, Lee G Wilke,[...]. Ann Surg Oncol 2017
36

Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.
Anita R Skandarajah, Susan Thomas, Kylie Shackleton, Laura Chin-Lenn, Geoffrey J Lindeman, G Bruce Mann. Breast 2017
8

Usability Testing of a Web-Based Decision Aid for Breast Cancer Risk Assessment Among Multi-Ethnic Women.
Austin M Coe, William Ueng, Jennifer M Vargas, Raven David, Alejandro Vanegas, Katherine Infante, Meghna Trivedi, Haeseung Yi, Jill Dimond, Katherine D Crew,[...]. AMIA Annu Symp Proc 2017
12

Managing hereditary breast cancer risk in women with and without ovarian cancer.
Mary Linton Peters, Judy E Garber, Nadine Tung. Gynecol Oncol 2017
8

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
Alvaro Peña, Sejal S Shah, Robert T Fazzio, Tanya L Hoskin, Rushin D Brahmbhatt, Tina J Hieken, James W Jakub, Judy C Boughey, Daniel W Visscher, Amy C Degnim. Breast Cancer Res Treat 2017
37

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.
Meghna S Trivedi, Austin M Coe, Alejandro Vanegas, Rita Kukafka, Katherine D Crew. Cancer Prev Res (Phila) 2017
23

How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
Katherine D Crew, Kathy S Albain, Dawn L Hershman, Joseph M Unger, Shelly S Lo. NPJ Breast Cancer 2017
23